{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T03:40:04Z","timestamp":1752291604542,"version":"3.41.2"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.1253\/circrep.cr-24-0175","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T18:08:13Z","timestamp":1748023693000},"page":"535-541","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Cognitive Function via Biomarkers in Japanese Patients With Chronic Heart Failure Treated With Angiotensin-Receptor-Neprilysin Inhibitor"],"prefix":"10.1253","volume":"7","author":[{"given":"Masaya","family":"Kogure","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukiko","family":"Kitani-Morii","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kitani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Oishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"},{"name":"Department of Cardiac Arrhythmia Research and Innovation, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutsugu","family":"Tatebe","sequence":"additional","affiliation":[{"name":"Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoaki","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[{"name":"Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Cannon JA, Moffitt P, Perez-Moreno AC, Walters MR, Broomfield NM, McMurray JJV, et al. Cognitive impairment and heart failure: Systematic review and meta-analysis. <i>J Card Fail<\/i> 2017; 23: 464\u2013475, doi:10.1016\/j.cardfail.2017.04.007.","DOI":"10.1016\/j.cardfail.2017.04.007"},{"key":"2","unstructured":"2. Leto L, Feola M. Cognitive impairment in heart failure patients. <i>J Geriatr Cardiol<\/i> 2014; 11: 316\u2013328, doi:10.11909\/j.issn.1671-5411.2014.04.007."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Manemann SM, Knopman DS, St Sauver J, Bielinski SJ, Chamberlain AM, Weston SA, et al. Alzheimer\u2019s disease and related dementias and heart failure: A community study. <i>J Am Geriatr Soc<\/i> 2022; 70: 1664\u20131672, doi:10.1111\/jgs.17752.","DOI":"10.1111\/jgs.17752"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Cermakova P, Eriksdotter M, Lund LH, Winblad B, Religa P, Religa D. Heart failure and Alzheimer\u2019s disease. <i>J Intern Med<\/i> 2015; 277: 406\u2013425, doi:10.1111\/joim.12287.","DOI":"10.1111\/joim.12287"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Machida K, Minamisawa M, Motoki H, Teramoto K, Okuma Y, Kanai M, et al. Clinical profile and prognosis of dementia in patients with acute decompensated heart failure: From the CURE-HF Registry. <i>Circ J<\/i> 2023; 88: 93\u2013102, doi:10.1253\/circj.CJ-23-0129.","DOI":"10.1253\/circj.CJ-23-0129"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Bayes-Genis A, Barallat J, Richards AM. A test in context: Neprilysin function, inhibition, and biomarker. <i>J Am Coll Cardiol<\/i> 2016; 68: 639\u2013653, doi:10.1016\/j.jacc.2016.04.060.","DOI":"10.1016\/j.jacc.2016.04.060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med<\/i> 2014; 371: 993\u20131004, doi:10.1056\/nejmoa1409077.","DOI":"10.1056\/NEJMoa1409077"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Bozkurt B, Nair AP, Misra A, Scott CZ, Mahar JH, Fedson S. Neprilysin inhibitors in heart failure: The science, mechanism of action, clinical studies, and unanswered questions. <i>JACC Basic Transl Sci<\/i> 2023; 8: 88\u2013105, doi:10.1016\/j.jacbts.2022.05.010.","DOI":"10.1016\/j.jacbts.2022.05.010"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Tsutsui H, Momomura S, Saito Y, Ito H, Yamamoto K, Sakata Y, et al. Long-term treatment with sacubitril\/valsartan in Japanese patients with chronic heart failure and reduced ejection fraction: Open-label extension of the PARALLEL-HF study. <i>Circ J<\/i> 2023; 88: 43\u201352, doi:10.1253\/circj.CJ-23-0174.","DOI":"10.1253\/circj.CJ-23-0174"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al. Metabolic regulation of brain A\u03b2 by neprilysin. <i>Science<\/i> 2001; 292: 1550\u20131552, doi:10.1126\/science.1059946.","DOI":"10.1126\/science.1059946"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics. <i>Science<\/i> 2002; 297: 353\u2013356, doi:10.1126\/science.1072994.","DOI":"10.1126\/science.1072994"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Grewal PK, Abboud A, Myserlis EP, Goldschmidt ME, Butler J, Skopicki HA, et al. Sacubitril\/valsartan and cognitive outcomes in heart failure with reduced ejection fraction. <i>JACC Adv<\/i> 2022; 2: 100372, doi:10.1016\/j.jacadv.2023.100372.","DOI":"10.1016\/j.jacadv.2023.100372"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Brum WS, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, et al. Effect of neprilysin inhibition on Alzheimer disease plasma biomarkers: A secondary analysis of a randomized clinical trial. <i>JAMA Neurol<\/i> 2023; 81: 197\u2013200, doi:10.1001\/jamaneurol2023.4719.","DOI":"10.1001\/jamaneurol.2023.4719"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Yoshinaga K, Matsushima T, Abe M, Takamura T, Togo H, Wakasugi N, et al. Age-disproportionate atrophy in Alzheimer\u2019s disease and Parkinson\u2019s disease spectra. <i>Alzheimer\u2019s Dement Diagn Assess Dis Monit<\/i> 2025; 17: e70048, doi:10.1002\/dad2.70048.","DOI":"10.1002\/dad2.70048"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Shinomoto M, Kasai T, Tatebe H, Kitani-Morii F, Ohmichi T, Fujino Y, et al. Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer\u2019s disease. <i>Transl Neurodegener<\/i> 2021; 10: 2, doi:10.1186\/s40035-020-00227-w.","DOI":"10.1186\/s40035-020-00227-w"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment. <i>Geriatr Gerontol Int<\/i> 2010; 10: 225\u2013232, doi:10.1111\/j.1447-0594.2010.00585.x.","DOI":"10.1111\/j.1447-0594.2010.00585.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tsoi KKF, Chan JYC, Hirai HW, Wong SYS, Kwok TCY. Cognitive tests to detect dementia: A systematic review and meta-analysis. <i>JAMA Intern Med<\/i> 2015; 175: 1450\u20131458, doi:10.1001\/jamainternmed.2015.2152.","DOI":"10.1001\/jamainternmed.2015.2152"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M. Declining expression of neprilysin in Alzheimer disease vasculature: Possible involvement in cerebral amyloid angiopathy. <i>J Neuropathol Exp Neurol<\/i> 2002; 61: 849\u2013856,doi:10.1093\/jnen\/61.10.849.","DOI":"10.1093\/jnen\/61.10.849"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Zhang H, Liu D, Wang Y, Huang H, Zhao Y, Zhou H. Meta-analysis of expression and function of neprilysin in Alzheimer\u2019s disease. <i>Neurosci Lett<\/i> 2017; 657: 69\u201376, doi:10.1016\/j.neulet.2017.07.060.","DOI":"10.1016\/j.neulet.2017.07.060"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Schoenfeld HA, West T, Verghese PB, Holubasch M, Shenoy N, Kagan D, et al. The effect of angiotensin receptor neprilysin inhibitor, sacubitril\/valsartan, on central nervous system amyloid-\u03b2 concentrations and clearance in the cynomolgus monkey. <i>Toxicol Appl Pharmacol<\/i> 2017; 323: 53\u201365, doi:10.1016\/j.taap.2017.03.014.","DOI":"10.1016\/j.taap.2017.03.014"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Langenickel TH, Tsubouchi C, Ayalasomayajula S, Pal P, Valentin M, Hinder M, et al. The effect of LCZ696 (sacubitril\/valsartan) on amyloid-\u03b2 concentrations in cerebrospinal fluid in healthy subjects. <i>Br J Clin Pharmacol<\/i> 2016; 81: 878\u2013890, doi:10.1111\/bcp.12861.","DOI":"10.1111\/bcp.12861"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cameron J, Worrall-Carter L, Page K, Stewart S, Ski CF. Screening for mild cognitive impairment in patients with heart failure: Montreal Cognitive Assessment versus Mini Mental State Exam. <i>Eur J Cardiovasc Nurs<\/i> 2013; 12: 252\u2013260, doi:101177\/1474515111435606.","DOI":"10.1177\/1474515111435606"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. <i>Arch Neurol<\/i> 2012; 69: 1318\u20131325, doi:10.1001\/archneurol2012.1282.","DOI":"10.1001\/archneurol.2012.1282"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: Pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. <i>Mol Neurodegener<\/i> 2017; 12: 63, doi:10.1186\/s13024-017-0206-8.","DOI":"10.1186\/s13024-017-0206-8"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK. Plasma phospho-tau in Alzheimer\u2019s disease: Towards diagnostic and therapeutic trial applications. <i>Mol Neurodegener<\/i> 2023; 18: 18, doi:10.1186\/s13024-023-00605-8.","DOI":"10.1186\/s13024-023-00605-8"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Ashton NJ, Janelidze S, Khleifat AA, Leuzy A, Ende EL van der, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. <i>Nat Commun<\/i> 2021; 12: 3400, doi:10.1038\/s41467-021-23620-z.","DOI":"10.1038\/s41467-021-23620-z"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Docherty KF, Campbell RT, Brooksbank KJM, Dreisbach JG, Forsyth P, Godeseth RL, et al. The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. <i>Circulation<\/i> 2021; 144: 199\u2013209, doi:10.1161\/circulationaha.121.054892.","DOI":"10.1161\/CIRCULATIONAHA.121.054892"},{"key":"28","unstructured":"28. ESC Press Office. Neprilysin inhibition does not affect cognitive function in patients with heart failure (26 Aug 2022). https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/Neprilysin-inhibition-does-not-affect-cognitive-function-in-patients-with-heart-failure (accessed March 2025)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. <i>Behav Res Methods<\/i> 2007; 39: 175\u2013191, doi:10.3758\/bf03193146.","DOI":"10.3758\/BF03193146"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Hansson O. Biomarkers for neurodegenerative diseases. <i>Nat Med<\/i> 2021; 27: 954\u2013963, doi:10.1038\/s41591-021-01382-x.","DOI":"10.1038\/s41591-021-01382-x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. <i>JAMA Neurol<\/i> 2019; 76: 791\u2013799, doi:10.1001\/jamaneurol2019.0765.","DOI":"10.1001\/jamaneurol.2019.0765"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Jack CR, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. <i>Alzheimer\u2019s Dement<\/i> 2024; 20: 5143\u20135169, doi:10.1002\/alz.13859.","DOI":"10.1002\/alz.13859"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ji B, Wang Q, Xue Q, Li W, Li X, Wu Y. The dual role of kinin\/kinin receptors system in Alzheimer\u2019s disease. <i>Front Mol Neurosci<\/i> 2019; 12: 234, doi:10.3389\/fnmol2019.00234.","DOI":"10.3389\/fnmol.2019.00234"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/7\/7_CR-24-0175\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T03:16:32Z","timestamp":1752290192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/7\/7_CR-24-0175\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-24-0175","relation":{},"ISSN":["2434-0790"],"issn-type":[{"type":"electronic","value":"2434-0790"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"article-number":"CR-24-0175"}}